SCHEMBL8285372

SCHEMBL8285372

NC(=O)C1(Nc2ccccc2)CCN(C2CCCCC2=O)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.50
CA1 P00915 4/20 0.46
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA13 Q8N1Q1 1/20 0.46
CA14 Q9ULX7 1/20 0.46
OPRM1 P35372 2/20 0.39
OPRD1 P41143 2/20 0.39
OPRK1 P41145 2/20 0.39
NPFFR1 Q9GZQ6 2/20 0.39
NPFFR2 Q9Y5X5 2/20 0.39
ALDH1A1 P00352 2/20 0.37
CYP2D6 P10635 1/20 0.37
MCL1 Q07820 1/20 0.37
KDM4E B2RXH2 2/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287289 0.89 SLC18A3 (0.40) SLC18A3CA1CA12CA2CA4
SCHEMBL8288001 0.86 MAPK1 (0.43) SLC18A3ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL14390556 0.84 SLC18A3 (0.46) SLC18A3OPRM1OPRD1OPRK1NPFFR1
SCHEMBL7878790 0.82 OPRM1 (0.49) CA1CA12CA2CA4CA5A
SCHEMBL7883748 0.82 OPRM1 (0.49) CA1CA12CA2CA4CA5A
SCHEMBL8287304 0.82 CA12 (0.42) CA1CA12CA2CA4CA5A
SCHEMBL8285368 0.80 SLC18A3 (0.51) SLC18A3CA1CA12CA2CA4
SCHEMBL7889459 0.79 OPRM1 (0.48) CA1CA12CA2CA4CA5A
SCHEMBL7878767 0.79 OPRM1 (0.48) CA1CA12CA2CA4CA5A
SCHEMBL7878770 0.79 OPRM1 (0.48) CA1CA12CA2CA4CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678177-B1 TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS HOFFMANN LA ROCHE (CH) 2007-11-28 EP disclosed
WO-2005040166-A1 TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2005-05-06 WO disclosed